TP53 and cancer: In murine STAT2 KO cancer cells, reduced STAT3 activation was accompanied by loss of STAT1 phosphorylation, which may reflect the influence of mutant p53 on STAT3 regulation in this cell line [38,39] in contrast to HCT116, which carry wild-type p53.